Does time-in-range matter? Perspectives from people with diabetes on the success of current therapies and the drivers of improved outcomes

76Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

After assessing patient perspectives on the success of current diabetes therapies and the factors that have the greatest impact on daily life, we show that time-in-range is a crucial outcome for people with diabetes and that current therapies are falling short on this metric. We also show that patients feel significant stress and worry, and they believe they are falling short in diet, exercise, and weight maintenance. In addition, they believe diet and exercise and in-range blood glucose are the biggest drivers of improved diabetes management and mindset. Together, these findings support the need for therapies that improve outcomes including and beyond A1C.

Cite

CITATION STYLE

APA

Runge, A. S., Kennedy, L., Brown, A. S., Dove, A. E., Levine, B. J., Koontz, S. P., … Wood, R. (2018). Does time-in-range matter? Perspectives from people with diabetes on the success of current therapies and the drivers of improved outcomes. Clinical Diabetes, 36(2), 112–119. https://doi.org/10.2337/cd17-0094

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free